|
Medarex, Novo Nordisk In Antibody Therapuetics Pact Dow Jones Newswires PRINCETON, N.J. -- Medarex Inc. (MEDX) and Novo-Nordisk A/S (NVO) formed an agreement to develop fully human antibody therapeutics. In a press release Tuesday, the companies said that under the terms of the agreement, Novo-Nordisk will develop and commercialize any human antibody products that may result from the agreement. Medarex will receive upfront payments and expects to receive milestone payments as well as royalties on commercial sales of resulting products. The companies plan to conbine Medarex`s UltiMAb human antibody development system and T-12 development with Novo-Nordisk`s protein therapeutics knowledge to create antibodies to multiple disease targets identified by Novo-Nordisk. Medarex develops monoclonal antibody-based therapeutics to fight cancer and other diseases. Novo-Novodisk, Copenhagen, makes a variety of pharmaceutical products such as insulin and other diabetes treatments. Company Web sites: http;//www.medarex.com; http;//www.novonordisk.com -Susan Willetts; Dow Jones Newswires; 201-938-5388 |
|
| aus der Diskussion: | Warum stürzt Medarex so ab??????? |
| Autor (Datum des Eintrages): | --er-- (09.01.01 14:14:38) |
| Beitrag: | 113 von 126 (ID:2660363) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |